Epidemiology of nontuberculous mycobacteria among patients with cystic fibrosis in Scandinavia


Qvist, Tavs, Gilljam, Marita, Jonsson, Bodil, Taylor-Robinson, David ORCID: 0000-0002-5828-7724, Jensen-Fangel, Soren, Wang, Mikala, Svahn, Anita, Kotz, Karsten, Hansson, Lennart, Hollsing, Annika et al (show 5 more authors) (2015) Epidemiology of nontuberculous mycobacteria among patients with cystic fibrosis in Scandinavia. JOURNAL OF CYSTIC FIBROSIS, 14 (1). pp. 46-52.

[img] Text
pdf - Published version
Download (344kB)

Abstract

<h4>Background</h4>Nontuberculous mycobacteria (NTM) are an emerging threat to cystic fibrosis (CF) patients but their epidemiology is not well described.<h4>Methods</h4>In this retrospective observational study we identified all Scandinavian CF patients with a positive NTM culture from airway secretions from 2000 to the end of 2012 and used national CF databases to describe microbiological and clinical characteristics.<h4>Results</h4>During the 13-year period 157 (11%) CF patients were culture positive for NTM at least once. Mycobacterium abscessus complex (MABSC) (45%) and Mycobacterium avium complex (MAC) (32%) were the predominant species with geographical differences in distribution. Younger patients were more prone to MABSC (p<0.01). Despite treatment, less than one-third of MABSC patients with repeated positive cultures cleared their infection and a quarter had a lung transplant or died.<h4>Conclusion</h4>NTM are significant CF pathogens and are becoming more prevalent in Scandinavia. MABSC and MAC appear to target distinct patient groups. Having multiple positive cultures despite treatment conveys a poor outcome.

Item Type: Article
Uncontrolled Keywords: Mycobacterium abscessus, Mycobacterium avium, Prevalence, Susceptibility
Depositing User: Symplectic Admin
Date Deposited: 05 Jan 2015 09:43
Last Modified: 16 Dec 2022 12:32
DOI: 10.1016/j.jcf.2014.08.002
Related URLs:
URI: https://livrepository.liverpool.ac.uk/id/eprint/2004246
Dimensions
Altmetric
CORE (COnnecting REpositories)